ClinicalTrials.Veeva

Menu

Topical Tranexamic Acid After Intravitreal Injections

R

Rambam Health Care Campus

Status

Unknown

Conditions

Subconjunctival Hemorrhage

Treatments

Other: Balanced Salt Solution
Drug: Tranexamic acid

Study type

Interventional

Funder types

Other

Identifiers

NCT04400916
0424-19-RMB

Details and patient eligibility

About

We aim to investigate whether topical administration of Tranexamic acid can reduce the occurence of subconjunctival hemorrahge after routine intravitreal injections for retinal conditions.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Subjects receiving intravitreal injections as part of their routine ophthalmological care

Exclusion criteria

Pregnancy, Oral contraceptives/HRT use, Known systemic autoimmune disease, Renal failure, active/suspected infection or inflammation in the treated eye, subconjunctival hemorrahge prior to inclusion, History of subarachnoid hemorrahge, thromboembolic events, increased risk for thromboembolic events, known sensitivity to the study drug

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups, including a placebo group

Topical tranexamic acid
Experimental group
Treatment:
Drug: Tranexamic acid
Topical BSS
Placebo Comparator group
Treatment:
Other: Balanced Salt Solution

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems